Alkermes Inc. plc (ALKS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ALKS. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 29,235,739 | $1.5B | INCREASED |
| State Street | 9,160,575 | $480M | DECREASED |
| BNY Mellon | 1,097,282 | $57M | INCREASED |
| Principal Financial Group | 983,822 | $52M | INCREASED |
| Victory Capital Management | 916,709 | $48M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Blair Curtis Jackson (President & CEO, Alkermes plc) | AWARD | 124,305 | $6M | 2026-08-05 |
| Blair Curtis Jackson (President & CEO, Alkermes plc) | AWARD | 93,229 | $5M | 2026-08-05 |
| David Joseph Gaffin (EVP, CLO, Alkermes, Inc.) | SELL | 2,034 | $99K | 2026-08-03 |
| Craig C. Hopkinson (EVP R&D, Chief Medical Officer) | EXERCISE | 4,896 | $120K | 2026-08-03 |
| Craig C. Hopkinson (EVP R&D, Chief Medical Officer) | EXERCISE | 104 | $2K | 2026-08-03 |
Full institutional holdings, insider history, and congressional trades for Alkermes Inc. plc on SentiSense.